Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia.
Shukaib ArslanJianying ZhangPrajwal DhakalJenna MoranNuthana NaidooJennifer LombardiVinod A PullarkatAnthony S SteinGuido MarcucciGeorge YaghmourVijaya R BhattAmir T FathiIbrahim AldossPublished in: American journal of hematology (2020)